MiraQ™ Cardiac Launched in the European Market

(Oslo, 13 October 2014) Medistim ASA (OSE: MEDI), a Norwegian company that develops and commercializes medical equipment for use in cardiac, vascular and transplant surgery, announces that they launch its new product MiraQ Cardiac in…

Read more

Record Sales in Fourth Quarter 2013

Medistim delivers record sales for a quarter with MNOK 52.2 (MNOK 49.7). Sales for 2013 ended at MNOK 191 (MNOK 183.8), which is a 3.9 % growth. Operating profit (EBIT) for the quarter ended at…

Read more

Results for the Third Quarter 2013

Sales for the quarter ended at MNOK 44.3 (MNOK 45.0). Sales as of September ended at MNOK 138.8 (MNOK 134.0). It was a strong quarter for procedural sales in the US with the highest number…

Read more

Healthier Veterans Magazine

Published: Winter 2012 (November) Cardiac surgeries performed at Washington DC VA Medical Center (DCVAMC) are now safer and more accurate thanks to the latest intra-operative tool, the Medistim VeriQC.  Winter-2012-Healthier-Veterans-News

Read more

Rikshospitalet has chosen VeriQ C

(Oslo, July 4th 2013) Medistim announces that Rikshospitalet has chosen to strengthen its quality assurance program of coronary bypass surgery by investing in Medistims top model, VeriQ C. (more…)

Read more

Q1 2013 financial report

Medistim reports sales revenues of MNOK 45,5 (45,1) and operating result of MNOK 7,3 (7,6) in the first quarter of 2013. The positive development in the USA continues, with 14% growth in revenues. The General…

Read more

Medistim Moves into new and modern facilities

(Oslo, March 18th, 2013) Medistim ASA announces that its corporate headquarter today is moving into new and modern facilities in Oslo. At the same time, Medistims sales and distribution center in Norway, Medistim Norge AS,…

Read more